- Home
- XBIO vs INBS Comparison
XBIO vs INBS Comparison
Compare XBIO & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- INBS
- Stock Information
- Founded
- XBIO N/A
- INBS 2016
- Country
- XBIO United States
- INBS United States
- Employees
- XBIO 4
- INBS N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- INBS Medical Specialities
- Sector
- XBIO Health Care
- INBS Health Care
- Exchange
- XBIO Nasdaq
- INBS Nasdaq
- Market Cap
- XBIO 6.3M
- INBS 6.3M
- IPO Year
- XBIO N/A
- INBS N/A
- Fundamental
- Price
- XBIO $4.06
- INBS $1.29
- Analyst Decision
- XBIO Hold
- INBS
- Analyst Count
- XBIO 1
- INBS 0
- Target Price
- XBIO N/A
- INBS N/A
- AVG Volume (30 Days)
- XBIO 22.9K
- INBS 115.2K
- Earning Date
- XBIO 11-12-2024
- INBS 02-07-2025
- Dividend Yield
- XBIO N/A
- INBS N/A
- EPS Growth
- XBIO N/A
- INBS N/A
- EPS
- XBIO N/A
- INBS N/A
- Revenue
- XBIO $2,523,427.00
- INBS $3,187,974.00
- Revenue This Year
- XBIO N/A
- INBS $280.88
- Revenue Next Year
- XBIO N/A
- INBS $126.26
- P/E Ratio
- XBIO N/A
- INBS N/A
- Revenue Growth
- XBIO 7.15
- INBS 55.29
- 52 Week Low
- XBIO $2.78
- INBS $1.00
- 52 Week High
- XBIO $5.20
- INBS $11.70
- Technical
- Relative Strength Index (RSI)
- XBIO 52.07
- INBS 40.01
- Support Level
- XBIO $3.92
- INBS $1.36
- Resistance Level
- XBIO $4.27
- INBS $1.69
- Average True Range (ATR)
- XBIO 0.25
- INBS 0.10
- MACD
- XBIO -0.04
- INBS -0.03
- Stochastic Oscillator
- XBIO 38.45
- INBS 11.11
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).